Seres Therapeutics, Inc. (MCRB) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$194
Total Return
-98.06%
CAGR
-54.54%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -2.93% |
| Median | -4.80% |
| Best | +109.05% |
| Worst | -71.05% |
| % of Windows Positive | 39.8% |
1-Year (252 Trading Days)
| Average | -34.12% |
| Median | -34.33% |
| Best | +160.28% |
| Worst | -91.05% |
| % of Windows Positive | 17.6% |
3-Year (756 Trading Days)
| Average | -88.71% |
| Median | -88.93% |
| Best | -77.77% |
| Worst | -97.07% |
| % of Windows Positive | 0.0% |
Risk Metrics
| Maximum Drawdown | -98.61% |
| Average Drawdown | -85.04% |
| Drawdown Duration | 1238 Trading Days (Unrecovered) |
| Sortino Ratio | -0.27 |
| Calmar Ratio | -0.55 |
| CVaR (5%) | -14.65% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -51.81% (-82.30% ann.) | $5181.35 | $0.00 | $0.00 | $0.00 |
| 2025 | -10.47% | $1046.58 | $0.00 | $0.00 | $0.00 |
| 2024 | -40.64% | $4064.32 | $0.00 | $0.00 | $0.00 |
| 2023 | -75.00% | $7500.02 | $0.00 | $0.00 | $0.00 |
| 2022 | -32.77% | $3277.33 | $0.00 | $0.00 | $0.00 |
| 2021 | -66.00% | $6600.01 | $0.00 | $0.00 | $0.00 |
| 2020 | +610.14% | +$61014.14 | $0.00 | $0.00 | $0.00 |
| 2019 | -23.67% | $2367.24 | $0.00 | $0.00 | $0.00 |
| 2018 | -55.42% | $5542.39 | $0.00 | $0.00 | $0.00 |
| 2017 | +2.42% | +$242.41 | $0.00 | $0.00 | $0.00 |
| 2016 | -71.79% | $7178.68 | $0.00 | $0.00 | $0.00 |
| 2015 partial | -31.73% (-52.37% ann.) | $3173.15 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | June 26, 2015 – February 19, 2020 | -92.98% | -43.50% | $9297.67 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -10.76% | -72.74% | $1076.16 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +879.89% | +3833.99% | +$87988.70 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -73.47% | -71.60% | $7346.58 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -33.83% | -35.50% | $3382.93 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -85.33% | -64.50% | $8533.31 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | -65.86% | -46.74% | $6585.57 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.